lunes, 29 de agosto de 2016

Financial Toxicity and Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute

Financial Toxicity and Cancer Treatment (PDQ®)—Health Professional Version - National Cancer Institute





National Cancer Institute

Financial Toxicity and Cancer Treatment (PDQ®)–Health Professional Version



SECTIONS



Introduction

A number of studies demonstrate that individuals with cancer are at higher risk of experiencing financial difficulty than are individuals without cancer.[1-5] This summary reviews the extant literature onfinancial toxicity among American cancer patients and survivors.
References
  1. Soni A: Trends in the Five Most Costly Conditions among the U.S. Civilian Institutionalized Population, 2002 and 2012. Statistical Brief 470. Rockville, Md: Agency for Healthcare Research and Quality, 2015. Available online. Last accessed June 9, 2016.
  2. Bradley CJ, Yabroff KR, Warren JL, et al.: Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients. Med Care 54 (5): 490-7, 2016. [PUBMED Abstract]
  3. Shih YC, Smieliauskas F, Geynisman DM, et al.: Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011. J Clin Oncol 33 (19): 2190-6, 2015. [PUBMED Abstract]
  4. Conti RM, Fein AJ, Bhatta SS: National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011. Health Aff (Millwood) 33 (10): 1721-7, 2014. [PUBMED Abstract]
  5. Ekwueme DU, Yabroff KR, Guy GP Jr, et al.: Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep 63 (23): 505-10, 2014. [PUBMED Abstract]
  • Updated: August 26, 2016

No hay comentarios:

Publicar un comentario